DK1175227T3 - Monoklonalt antistof som er rettet mod celler fra humant nyrekarcinom - Google Patents

Monoklonalt antistof som er rettet mod celler fra humant nyrekarcinom

Info

Publication number
DK1175227T3
DK1175227T3 DK00925425T DK00925425T DK1175227T3 DK 1175227 T3 DK1175227 T3 DK 1175227T3 DK 00925425 T DK00925425 T DK 00925425T DK 00925425 T DK00925425 T DK 00925425T DK 1175227 T3 DK1175227 T3 DK 1175227T3
Authority
DK
Denmark
Prior art keywords
monoclonal antibody
human renal
carcinoma cells
renal carcinoma
antibody targeting
Prior art date
Application number
DK00925425T
Other languages
English (en)
Inventor
Francois Hirsch
Eric Angevin
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of DK1175227T3 publication Critical patent/DK1175227T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/106—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from kidney or bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3038—Kidney, bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00925425T 1999-05-10 2000-05-10 Monoklonalt antistof som er rettet mod celler fra humant nyrekarcinom DK1175227T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9905942A FR2793497B1 (fr) 1999-05-10 1999-05-10 Anticorps monoclonal dirige contre les cellules de carcinome renal humain
PCT/FR2000/001258 WO2000067792A1 (fr) 1999-05-10 2000-05-10 Anticorps monoclonal dirige contre les cellules de carcinome renal humain

Publications (1)

Publication Number Publication Date
DK1175227T3 true DK1175227T3 (da) 2007-08-27

Family

ID=9545417

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00925425T DK1175227T3 (da) 1999-05-10 2000-05-10 Monoklonalt antistof som er rettet mod celler fra humant nyrekarcinom

Country Status (14)

Country Link
US (1) US7074613B1 (da)
EP (1) EP1175227B1 (da)
JP (1) JP2002543811A (da)
AT (1) ATE359091T1 (da)
AU (1) AU781426B2 (da)
CA (1) CA2373631A1 (da)
CY (1) CY1107060T1 (da)
DE (1) DE60034330T2 (da)
DK (1) DK1175227T3 (da)
ES (1) ES2284493T3 (da)
FR (1) FR2793497B1 (da)
IL (2) IL146396A0 (da)
PT (1) PT1175227E (da)
WO (1) WO2000067792A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793497B1 (fr) 1999-05-10 2003-04-18 Centre Nat Rech Scient Anticorps monoclonal dirige contre les cellules de carcinome renal humain
US20040077081A1 (en) 2001-02-07 2004-04-22 Egbert Oosterwijk Hybridoma cell line g250 and its use for producing monoclonal antibodies
MXPA03006992A (es) * 2001-02-07 2003-11-18 Wilex Ag Linea de celulas hibridoma g250 y su uso para la produccion de anticuerpos monoclonales.
EP2067472A1 (en) * 2002-01-02 2009-06-10 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20050074901A1 (en) * 2002-02-13 2005-04-07 John Castracane Methods and assays for detecting and quantifying the human p53 inducible gene protein
CA2492057A1 (en) 2002-07-01 2004-01-08 Wilex Ag Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas
CN111732660B (zh) * 2020-07-31 2020-12-29 河北佑仁生物科技有限公司 骨髓间充质干细胞和单克隆抗体联合治疗癌症

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650756A (en) * 1981-08-31 1987-03-17 Sloan Kettering Institute For Cancer Research Monoclonal antibodies to cell surface antigens of human renal cancer
US4713352A (en) * 1981-08-31 1987-12-15 Sloan-Kettering Institute For Cancer Reseach Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma
EP0119528B1 (en) * 1983-03-11 1992-05-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human renal cancer antigens and method
EP0366707A1 (en) * 1987-05-06 1990-05-09 OOSTERWIJK, Egbert Monoclonal antibodies to renal cell carcinoma
US5145773A (en) 1989-05-25 1992-09-08 Sloan-Kettering Institute For Cancer Research Method to detect sensitivity to alpha-interferon therapy
US5270202A (en) * 1989-11-03 1993-12-14 Syamal Raychaudhuri Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
US6235280B1 (en) * 1996-04-12 2001-05-22 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
FR2793497B1 (fr) 1999-05-10 2003-04-18 Centre Nat Rech Scient Anticorps monoclonal dirige contre les cellules de carcinome renal humain
AU2001261371A1 (en) * 2000-05-16 2001-11-26 New York University Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions containing same and method for using same

Also Published As

Publication number Publication date
EP1175227B1 (fr) 2007-04-11
US7074613B1 (en) 2006-07-11
IL146396A0 (en) 2002-07-25
WO2000067792A9 (fr) 2002-09-12
DE60034330D1 (de) 2007-05-24
CA2373631A1 (fr) 2000-11-16
EP1175227A1 (fr) 2002-01-30
IL146396A (en) 2007-06-17
WO2000067792A1 (fr) 2000-11-16
ATE359091T1 (de) 2007-05-15
ES2284493T3 (es) 2007-11-16
FR2793497A1 (fr) 2000-11-17
PT1175227E (pt) 2007-07-18
DE60034330T2 (de) 2007-12-20
FR2793497B1 (fr) 2003-04-18
AU4415100A (en) 2000-11-21
CY1107060T1 (el) 2012-10-24
JP2002543811A (ja) 2002-12-24
AU781426B2 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
CY1107060T1 (el) Μονοκλωνικο αντισωμα κατευθυνομενο κατα των κυτταρων του ανθρωπινου νεφρικου καρκινωματος
IS8950A (is) Einklóna mótefni gegn CTLA-4 úr manni.
NZ337413A (en) Antibodies that bind to Prostate Stem Cell Antigen (PSCA) to treat prostate cancer.
ZA945364B (en) Antibodies specific for human prostate glandular kallikrein
DK1950302T3 (da) Streptokok-antigener.
NO20025831D0 (no) System for seismisk datainnsamling som benytter oppfangningsstasjoner plassert på havbunnen
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
NL1010321A1 (nl) Wafeldrager.
EP1080227A4 (en) NEW METHOD FOR DIAGNOSING, MONITORING AND STADIFYING COLON CANCER
MXPA03011306A (es) Metodos para la preparacion y uso de 1a,24 (s) - hidroxivitamina d2.
TR199800604A3 (tr) Anti-fas antikorlari.
MXPA01010437A (es) Complejo epitope fab del anticuerpo monoclonal 2f5 de neutralizacion cruzada de hiv-1.
IT1301682B1 (it) Procedimento per l'ottenimento di (per)fluoropolieterei sostituitiad uno o entrambi i terminali con un atomo di alogeno.
TR199701482T1 (xx) Osteoporozu �nlemek i�in alendronat kullan�lmas�.
NO974852L (no) Humant <beta>2-integrin-<alfa>-subenhet
NO20005833D0 (no) Humaniserte antistoffer som gjenkjenner verotoksin II og cellelinje som produserer det samme
DE60317462D1 (de) Neuer monoklonaler antikörper und antigene gegen nematodenlarven
NO894555D0 (no) Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet.
BR1100555B1 (pt) anticorpos monoclonais humanizados.
Kudo THE NECESSITY OF CONSIDERING SOCIAL RELATIONS IN THE DEVELOPMENT OF HOUSING FOR THE ELDERLY-SURVEY RESULTS OF SILVER PEER RESIDENTS
ITBO980261A1 (it) Apri bustina.
IT239134Y1 (it) Dispositivo aspirante, particolarmente per w.c.
FIU970517U0 (fi) Monitoiminen kone, teräs -ym. putken osien valmistukseen
ITGE950030V0 (it) Lumino per sepolcri, immagini votive e simili.
ITFO980038U1 (it) Europallet monoblocco.